CESAMET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cesamet, and what generic alternatives are available?
Cesamet is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in CESAMET is nabilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nabilone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CESAMET?
- What are the global sales for CESAMET?
- What is Average Wholesale Price for CESAMET?
Summary for CESAMET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Clinical Trials: | 17 |
Patent Applications: | 4,344 |
Drug Prices: | Drug price information for CESAMET |
What excipients (inactive ingredients) are in CESAMET? | CESAMET excipients list |
DailyMed Link: | CESAMET at DailyMed |
Recent Clinical Trials for CESAMET
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Samuel Lunenfeld Research Institute, Mount Sinai Hospital | N/A |
New York State Psychiatric Institute | Phase 2 |
National Institute of Mental Health (NIMH) | Phase 1/Phase 2 |
Pharmacology for CESAMET
Drug Class | Cannabinoid |
US Patents and Regulatory Information for CESAMET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | CESAMET | nabilone | CAPSULE;ORAL | 018677-001 | Dec 26, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CESAMET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | CESAMET | nabilone | CAPSULE;ORAL | 018677-001 | Dec 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | CESAMET | nabilone | CAPSULE;ORAL | 018677-001 | Dec 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | CESAMET | nabilone | CAPSULE;ORAL | 018677-001 | Dec 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | CESAMET | nabilone | CAPSULE;ORAL | 018677-001 | Dec 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CESAMET
See the table below for patents covering CESAMET around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 45662 | 1-HYDROXY-3-ALKYL-HEXAHYDRO-DIBENZO(B,D)PYRAN-9-ONES AND PSYCHOTROPIC OR SEDATIVE DRUGS CONTAINING THEM | ⤷ Sign Up |
Sweden | 7413832 | ⤷ Sign Up | |
German Democratic Republic | 116229 | ⤷ Sign Up | |
Netherlands | 180979 | ⤷ Sign Up | |
Philippines | 12320 | DIBENZO(B,D)PYRANONE DISPERSIONS | ⤷ Sign Up |
South Africa | 7405870 | ⤷ Sign Up | |
Poland | 94965 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |